Biden’s Global Health Legacy and a Superbug Miniseries

Editors' Note

Millions of Americans watched President Joe Biden pass the torch to nominee and Vice President Kamala Harris at the Democratic National Convention on Monday. CFR Senior Fellow David P. Fidler reflects on Biden's legacy on global health, writing that the administration "has raised questions about what U.S. global health engagement means for a divided nation in a fragmented world."

Next, scientist and medical writer Zeena Nackerdien kicks off a miniseries on antimicrobial resistance (AMR), which will be an agenda item at next month's UN General Assembly. Nackerdien outlines how nurses—with their expertise in disease prevention, communication, and surveillance—are well positioned at the front line of patient care to fight against AMR, if given the appropriate tools.

Johanne Lisa Jensen-LeBlanc, from the University of Southern Denmark, then highlights how Canada needs to align its AMR action plan with the values of Indigenous peoples, who face a higher burden of the life-threatening infections.

Charlotte Bull, a recent graduate from the University of British Columbia, wraps up the series by outlining how China, the world's largest producer and consumer of antibiotics, should step up its involvement in global AMR governance by spearheading international collaboration on the issue.

Until next week!—Nsikan Akpan, Managing Editor, and Caroline Kantis, Associate Editor